Establishing Acceptance Limits for Uniformity of Dosage Units: Part Two
The author describes how to establish acceptance limits for acceptance value (AV) data for process validation batches, typical characteristics of AV distributions, and how to derive relevant constants for AV control charts in annual product review and continued process verification reports.
Africa Studio/shutterstock.com
Abstract
The concept of sampling distribution of acceptance value (AV) was introduced in Part One of this article series. In Part Two, the author describes how to establish the corresponding acceptance limits for AV data for process validation batches, the typical characteristics of AV distributions, and finally, how to derive relevant constants for AV control charts in annual product review and continued process verification reports.
Click here to view a PDF of this article.
Peer-review article
Submitted: Jan. 17, 2017
Accepted: March 8, 2017
About the author
Pramote Cholayudth is a validation consultant to Biolab Co., Ltd., in Thailand. He is the founder and manager of PM Consult, cpramote2000@yahoo.com.
Article Details
Pharmaceutical Technology
Vol. 41, No. 8
Pages: 30–39
Citation:
When referring to this article, please cite it as P. Cholayudth, "Establishing Acceptance Limits for Uniformity of Dosage Units: Part Two," Pharmaceutical Technology 41 (8) 2017.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
